ELIQUENT Life Sciences
Kathleen Retterson is an accomplished executive with extensive experience in regulatory affairs and pharmaceutical operations. Currently serving as Senior Vice President of Regulatory Affairs Practice, CMC at ELIQUENT Life Sciences, Kathleen has held significant leadership positions including Vice President of Pharmaceutical Operations at Spectrum Pharmaceuticals, General Manager and Site Head at Charles River Laboratories, and Vice President at Genzyme. Additionally, Kathleen served as Vice President and General Manager of Amgen Rhode Island, overseeing operations at both the Thousands Oaks site and contract manufacturing. Kathleen's educational background includes an MBA in Finance from Stanford University Graduate School of Business and a BA with Honors in American History from Brown University.
This person is not in any teams
This person is not in any offices
ELIQUENT Life Sciences
We are expert consultants delivering the answers and solutions that life sciences innovators need to gain and maintain market authorization for their products. Our unprecedented assembly of regulatory leaders, industry experts, and technical specialists collaborate seamlessly to unlock excellence throughout the product lifecycle. We are the convergence of regulatory expertise and technical capabilities across the therapeutic landscape. From thought to finish, concept to commerce, and strategy to execution— ELIQUENT Life Sciences is the singular regulatory resource that clients around the world trust. ELIQUENT Life Sciences is comprised of five global consultancies working as a collective, coordinated regulatory team. The ELIQUENT team includes: VALIDANT: A full-service life science consulting firm providing strategy, execution, and ongoing support for a range of regulatory, compliance, and quality needs. GREENLEAF HEALTH: A leading FDA regulatory consulting firm that provides strategic and technical guidance to pharmaceutical, biotechnology, and medical device companies. DATAREVIVE: A regulatory consultancy firm with expertise to deliver CMC, preclinical, clinical, and GxP expertise to innovators seeking product approvals in major global markets. ORIEL STAT-A-MATRIX: A global leader in training and consulting for business process improvement, regulatory compliance, and quality management systems. IDEC: A regionally specialized regulatory guidance and end-to-end product support for pharmaceutical innovators seeking approval in the Japanese market. Together, ELIQUENT redefines regulatory consulting with a full-service approach and comprehensive solutions that bridge the spectrum of regulatory challenges. Learn more at ELIQUENT.com